个性化文献订阅>期刊> Archives of Biochemistry and Biophysics
 

TOX4 and its binding partners recognize DNA adducts generated by platinum anticancer drugs

  作者 du Puch, CBM; Barbier, E; Kraut, A; Coute, Y; Fuchs, J; Buhot, A; Livache, T; Seve, M; Favier, A; Douki, T; Gasparutto, D; Sauvaigo, S; Breton, J  
  选自 期刊  Archives of Biochemistry and Biophysics ;  卷期  2011年507-2;  页码  296-303  
  关联知识点  
 

[摘要]Platinating agents are commonly prescribed anticancer drugs damaging DNA. Induced lesions are recognized by a wide range of proteins. These are involved in cellular mechanisms such as DNA repair, mediation of cytotoxicity or chromatin remodeling. They therefore constitute crucial actors to understand pharmacology of these drugs. To expand our knowledge about this subproteome, we developed a ligand fishing trap coupled to high throughput proteomic tools. This trap is made of damaged plasmids attached to magnetic beads, and was exposed to cell nuclear extracts. Retained proteins were identified by nano-HPLC coupled to tandem mass spectrometry. This approach allowed us to establish a list of 38 proteins interacting with DNA adducts generated by cisplatin, oxaliplatin and satraplatin. Some of them were already known interactome members like high mobility group protein 1 (HMGB1) or the human upstream binding factor (hUBF), but we also succeeded in identifying unexpected proteins such as TOX HMG box family member 4 (TOX4), phosphatase 1 nuclear targeting subunit (PNUTS), and WD repeat-containing protein 82 (WDR82), members of a recently discovered complex. Interaction between TOX4 and platinated DNA was subsequently validated by surface plasmon resonance imaging (SPRi). These interactions highlight new cellular responses to DNA damage induced by chemotherapeutic agents. (C) 2010 Elsevier Inc. All rights reserved.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内